Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Ciglitazone
45
CHF
CHF 45.00
In stock
AG-CR1-0033-M0011 mgCHF 45.00
AG-CR1-0033-M0055 mgCHF 110.00
AG-CR1-0033-M02525 mgCHF 440.00
Product Details | |
---|---|
Synonyms | (±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione; U-63287 |
Product Type | Chemical |
Properties | |
Formula |
C18H23NO3S |
MW | 333.5 |
CAS | 74772-77-3 |
RTECS | XJ5813700 |
Purity Chemicals | ≥98% (HPLC) |
Appearance | Off-white solid. |
Solubility | Soluble in DMSO or 100% ethanol. |
Identity | Determined by 1H-NMR. |
Other Product Data |
Stock solutions are stable for up to 3 months when stored at -20°C. |
InChi Key | YZFWTZACSRHJQD-UHFFFAOYSA-N |
Smiles | CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Selective PPARγ agonist (EC50=3 µM) [1].
- Hypoglycemic agent [2, 3].
- Angiogenesis inhibitor [4].
- Anti-inflammatory [5].
- Apoptosis inducer [6].
Product References
- The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones: T.M. Willson, et al.; J. Med. Chem. 39, 665 (1996)
- Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent: T. Fujita, et al.; Diabetes 32, 804 (1983)
- [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents: B.C. Cantello, et al.; J. Med. Chem. 37, 3977 (1994)
- Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo: X. Xin, et al.; J. Biol. Chem. 274, 9116 (1999)
- The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice: M.E. Stegenga, et al.; Crit. Care Med. 37, 614 (2009)
- Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock: R.S. Chima, et al.; Int. J. Clin. Exp. Med. 3, 1 (2010)